世界の植物由来医薬品市場予測2023-2029:丸薬、錠剤、カプセル

【英語タイトル】Botanical Plant Derived Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2465)・商品コード:MMG23FB2465
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:67
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の植物由来医薬品市場規模と予測を収録しています。・世界の植物由来医薬品市場:売上、2018年-2023年、2024年-2029年
・世界の植物由来医薬品市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の植物由来医薬品市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「丸薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

植物由来医薬品のグローバル主要企業は、Abbott Laboratories、Eli Lilly、Medigene、Pfizer、Lupin、Johnson & Johnson、Ranbaxy Laboratories、Novartis International AG、Glaxosmithkline、Leo Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、植物由来医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の植物由来医薬品市場:タイプ別、2018年-2023年、2024年-2029年
世界の植物由来医薬品市場:タイプ別市場シェア、2022年
・丸薬、錠剤、カプセル

世界の植物由来医薬品市場:用途別、2018年-2023年、2024年-2029年
世界の植物由来医薬品市場:用途別市場シェア、2022年
・薬局、クリニック、その他

世界の植物由来医薬品市場:地域・国別、2018年-2023年、2024年-2029年
世界の植物由来医薬品市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における植物由来医薬品のグローバル売上、2018年-2023年
・主要企業における植物由来医薬品のグローバル売上シェア、2022年
・主要企業における植物由来医薬品のグローバル販売量、2018年-2023年
・主要企業における植物由来医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Abbott Laboratories、Eli Lilly、Medigene、Pfizer、Lupin、Johnson & Johnson、Ranbaxy Laboratories、Novartis International AG、Glaxosmithkline、Leo Pharma

*************************************************************

・調査・分析レポートの概要
植物由来医薬品市場の定義
市場セグメント
世界の植物由来医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の植物由来医薬品市場規模
世界の植物由来医薬品市場規模:2022年 VS 2029年
世界の植物由来医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの植物由来医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の植物由来医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:丸薬、錠剤、カプセル
植物由来医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:薬局、クリニック、その他
植物由来医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別植物由来医薬品市場規模 2022年と2029年
地域別植物由来医薬品売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Abbott Laboratories、Eli Lilly、Medigene、Pfizer、Lupin、Johnson & Johnson、Ranbaxy Laboratories、Novartis International AG、Glaxosmithkline、Leo Pharma

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Botanical Plant Derived Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Botanical Plant Derived Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Botanical Plant Derived Drug Overall Market Size
2.1 Global Botanical Plant Derived Drug Market Size: 2022 VS 2029
2.2 Global Botanical Plant Derived Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Botanical Plant Derived Drug Players in Global Market
3.2 Top Global Botanical Plant Derived Drug Companies Ranked by Revenue
3.3 Global Botanical Plant Derived Drug Revenue by Companies
3.4 Top 3 and Top 5 Botanical Plant Derived Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Botanical Plant Derived Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Botanical Plant Derived Drug Players in Global Market
3.6.1 List of Global Tier 1 Botanical Plant Derived Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Botanical Plant Derived Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Botanical Plant Derived Drug Market Size Markets, 2022 & 2029
4.1.2 Pill
4.1.3 Tablet
4.1.4 Capsule
4.2 By Type – Global Botanical Plant Derived Drug Revenue & Forecasts
4.2.1 By Type – Global Botanical Plant Derived Drug Revenue, 2018-2023
4.2.2 By Type – Global Botanical Plant Derived Drug Revenue, 2024-2029
4.2.3 By Type – Global Botanical Plant Derived Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Botanical Plant Derived Drug Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Clinic Center
5.1.4 Others
5.2 By Application – Global Botanical Plant Derived Drug Revenue & Forecasts
5.2.1 By Application – Global Botanical Plant Derived Drug Revenue, 2018-2023
5.2.2 By Application – Global Botanical Plant Derived Drug Revenue, 2024-2029
5.2.3 By Application – Global Botanical Plant Derived Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Botanical Plant Derived Drug Market Size, 2022 & 2029
6.2 By Region – Global Botanical Plant Derived Drug Revenue & Forecasts
6.2.1 By Region – Global Botanical Plant Derived Drug Revenue, 2018-2023
6.2.2 By Region – Global Botanical Plant Derived Drug Revenue, 2024-2029
6.2.3 By Region – Global Botanical Plant Derived Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Botanical Plant Derived Drug Revenue, 2018-2029
6.3.2 US Botanical Plant Derived Drug Market Size, 2018-2029
6.3.3 Canada Botanical Plant Derived Drug Market Size, 2018-2029
6.3.4 Mexico Botanical Plant Derived Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Botanical Plant Derived Drug Revenue, 2018-2029
6.4.2 Germany Botanical Plant Derived Drug Market Size, 2018-2029
6.4.3 France Botanical Plant Derived Drug Market Size, 2018-2029
6.4.4 U.K. Botanical Plant Derived Drug Market Size, 2018-2029
6.4.5 Italy Botanical Plant Derived Drug Market Size, 2018-2029
6.4.6 Russia Botanical Plant Derived Drug Market Size, 2018-2029
6.4.7 Nordic Countries Botanical Plant Derived Drug Market Size, 2018-2029
6.4.8 Benelux Botanical Plant Derived Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Botanical Plant Derived Drug Revenue, 2018-2029
6.5.2 China Botanical Plant Derived Drug Market Size, 2018-2029
6.5.3 Japan Botanical Plant Derived Drug Market Size, 2018-2029
6.5.4 South Korea Botanical Plant Derived Drug Market Size, 2018-2029
6.5.5 Southeast Asia Botanical Plant Derived Drug Market Size, 2018-2029
6.5.6 India Botanical Plant Derived Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Botanical Plant Derived Drug Revenue, 2018-2029
6.6.2 Brazil Botanical Plant Derived Drug Market Size, 2018-2029
6.6.3 Argentina Botanical Plant Derived Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Botanical Plant Derived Drug Revenue, 2018-2029
6.7.2 Turkey Botanical Plant Derived Drug Market Size, 2018-2029
6.7.3 Israel Botanical Plant Derived Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Botanical Plant Derived Drug Market Size, 2018-2029
6.7.5 UAE Botanical Plant Derived Drug Market Size, 2018-2029
7 Botanical Plant Derived Drug Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Botanical Plant Derived Drug Major Product Offerings
7.1.4 Abbott Laboratories Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Botanical Plant Derived Drug Major Product Offerings
7.2.4 Eli Lilly Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Medigene
7.3.1 Medigene Company Summary
7.3.2 Medigene Business Overview
7.3.3 Medigene Botanical Plant Derived Drug Major Product Offerings
7.3.4 Medigene Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.3.5 Medigene Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Botanical Plant Derived Drug Major Product Offerings
7.4.4 Pfizer Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Lupin
7.5.1 Lupin Company Summary
7.5.2 Lupin Business Overview
7.5.3 Lupin Botanical Plant Derived Drug Major Product Offerings
7.5.4 Lupin Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.5.5 Lupin Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Botanical Plant Derived Drug Major Product Offerings
7.6.4 Johnson & Johnson Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Ranbaxy Laboratories
7.7.1 Ranbaxy Laboratories Company Summary
7.7.2 Ranbaxy Laboratories Business Overview
7.7.3 Ranbaxy Laboratories Botanical Plant Derived Drug Major Product Offerings
7.7.4 Ranbaxy Laboratories Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.7.5 Ranbaxy Laboratories Key News & Latest Developments
7.8 Novartis International AG
7.8.1 Novartis International AG Company Summary
7.8.2 Novartis International AG Business Overview
7.8.3 Novartis International AG Botanical Plant Derived Drug Major Product Offerings
7.8.4 Novartis International AG Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.8.5 Novartis International AG Key News & Latest Developments
7.9 Glaxosmithkline
7.9.1 Glaxosmithkline Company Summary
7.9.2 Glaxosmithkline Business Overview
7.9.3 Glaxosmithkline Botanical Plant Derived Drug Major Product Offerings
7.9.4 Glaxosmithkline Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.9.5 Glaxosmithkline Key News & Latest Developments
7.10 Leo Pharma
7.10.1 Leo Pharma Company Summary
7.10.2 Leo Pharma Business Overview
7.10.3 Leo Pharma Botanical Plant Derived Drug Major Product Offerings
7.10.4 Leo Pharma Botanical Plant Derived Drug Revenue in Global Market (2018-2023)
7.10.5 Leo Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Botanical Plant Derived Drug Market Opportunities & Trends in Global Market
Table 2. Botanical Plant Derived Drug Market Drivers in Global Market
Table 3. Botanical Plant Derived Drug Market Restraints in Global Market
Table 4. Key Players of Botanical Plant Derived Drug in Global Market
Table 5. Top Botanical Plant Derived Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Botanical Plant Derived Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Botanical Plant Derived Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Botanical Plant Derived Drug Product Type
Table 9. List of Global Tier 1 Botanical Plant Derived Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Botanical Plant Derived Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Botanical Plant Derived Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Botanical Plant Derived Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Botanical Plant Derived Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Botanical Plant Derived Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Botanical Plant Derived Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Botanical Plant Derived Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Botanical Plant Derived Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Botanical Plant Derived Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Botanical Plant Derived Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Botanical Plant Derived Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Botanical Plant Derived Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Botanical Plant Derived Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Botanical Plant Derived Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Botanical Plant Derived Drug Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Botanical Plant Derived Drug Product Offerings
Table 32. Abbott Laboratories Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Botanical Plant Derived Drug Product Offerings
Table 36. Eli Lilly Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. Medigene Company Summary
Table 39. Medigene Botanical Plant Derived Drug Product Offerings
Table 40. Medigene Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Medigene Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Botanical Plant Derived Drug Product Offerings
Table 44. Pfizer Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Lupin Company Summary
Table 47. Lupin Botanical Plant Derived Drug Product Offerings
Table 48. Lupin Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Lupin Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Botanical Plant Derived Drug Product Offerings
Table 52. Johnson & Johnson Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Ranbaxy Laboratories Company Summary
Table 55. Ranbaxy Laboratories Botanical Plant Derived Drug Product Offerings
Table 56. Ranbaxy Laboratories Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Ranbaxy Laboratories Key News & Latest Developments
Table 58. Novartis International AG Company Summary
Table 59. Novartis International AG Botanical Plant Derived Drug Product Offerings
Table 60. Novartis International AG Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis International AG Key News & Latest Developments
Table 62. Glaxosmithkline Company Summary
Table 63. Glaxosmithkline Botanical Plant Derived Drug Product Offerings
Table 64. Glaxosmithkline Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Glaxosmithkline Key News & Latest Developments
Table 66. Leo Pharma Company Summary
Table 67. Leo Pharma Botanical Plant Derived Drug Product Offerings
Table 68. Leo Pharma Botanical Plant Derived Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Leo Pharma Key News & Latest Developments
List of Figures
Figure 1. Botanical Plant Derived Drug Segment by Type in 2022
Figure 2. Botanical Plant Derived Drug Segment by Application in 2022
Figure 3. Global Botanical Plant Derived Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Botanical Plant Derived Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Botanical Plant Derived Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Botanical Plant Derived Drug Revenue in 2022
Figure 8. By Type - Global Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Botanical Plant Derived Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Botanical Plant Derived Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 16. US Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 20. Germany Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 28. China Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Botanical Plant Derived Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Botanical Plant Derived Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Medigene Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lupin Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Ranbaxy Laboratories Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis International AG Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Glaxosmithkline Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Leo Pharma Botanical Plant Derived Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の植物由来医薬品市場予測2023-2029:丸薬、錠剤、カプセル] (コード:MMG23FB2465)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の植物由来医薬品市場予測2023-2029:丸薬、錠剤、カプセル]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆